Trials / Completed
CompletedNCT06797674
A Study of the Effect Efavirenz on the Plasma Levels of MK-7602 in Healthy Participants (MK-7602-005)
A Clinical Study to Evaluate the Effect of Multiple Doses of Efavirenz on Single-Dose Pharmacokinetics of MK-7602 in Healthy Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The goal of the study is to learn what happens to levels of MK-7602 in a healthy person's body over time. Researchers will compare what happens to MK-7602 in the body when it is given with or without another medicine called efavirenz, and when it is given with or without a meal.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK-7602 | Capsule |
| DRUG | Efavirenz | Tablet |
Timeline
- Start date
- 2025-02-10
- Primary completion
- 2025-08-12
- Completion
- 2025-08-12
- First posted
- 2025-01-28
- Last updated
- 2025-08-22
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06797674. Inclusion in this directory is not an endorsement.